Current management of pediatric acute otitis media

References

• Culpepper L, Froom J, Bartelds AI et al. Acute otitis media in adults: a report from the International Primary Care Network. J. Am. Board Fam. Pract.6, 333–339 (1993).
   PubMedGoogle Scholar
• Faden H, Duffy L, Boeve M. Otitis media: back to basics. Pediatr. Infect. Dis. J.7, 1105–1112 (1998).
   Google Scholar
• Pelton SI. New concepts in the pathophysiology and management of middle ear disease in childhood. Drugs52(Suppl. 2), 62–66; discussion 66–67 (1996).
   PubMedGoogle Scholar
• Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis.160, 83–94 (1989).
   PubMed Web of Science ®Google Scholar
• Klein JO, Teele DW, Pelton SI. New concepts in otitis media: results of investigations of the Greater Boston Otitis Media Study Group. Adv. Pediatr.39, 127–156 (1992).
   PubMedGoogle Scholar
• Hoberman A, Marchant CD, Kaplan SL, Feldman S. Treatment of acute otitis media consensus recommendations. Clin. Pediatr. (Phila.)41, 373–390 (2002).
   PubMed Web of Science ®Google Scholar
• Dagan R, Barkay G, Leibovitz E, Dreifuss E, Greenberg D. Will reduction of antibiotic use reduce antibiotic resistance? The pneumococcus paradigm. Pediatr. Infect. Dis. J.25, 981–986 (2006).
   PubMedGoogle Scholar
• Giebink GS. The microbiology of otitis media. Pediatr. Infect. Dis. J.8, S18–S20 (1989).
   PubMed Web of Science ®Google Scholar
• Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr. Infect. Dis. J.11, S7–S11 (1992).
   PubMed Web of Science ®Google Scholar
• Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr. Infect. Dis. J.16, 449–456 (1997).
   PubMedGoogle Scholar
• Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob. Agents Chemother.42, 589–595 (1998).
   PubMed Web of Science ®Google Scholar
• Baquero F. Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Microb. Drug Resist.1, 115–120 (1993).
   Google Scholar
• Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr. Infect. Dis. J.15, 932–934 (1996).
   PubMedGoogle Scholar
• Black S, Shinefield H, Fireman B et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J.19, 187–195 (2000).
   PubMed Web of Science ®Google Scholar
• Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr. Infect. Dis. J.22, 10–16 (2003).
   PubMed Web of Science ®Google Scholar
• Eskola J, Kilpi T, Palmu A et al. Efficay of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med.344, 403–409 (2001).
   PubMed Web of Science ®Google Scholar
• Casey J, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr. Infect. Dis. J.23, 824–828 (2004).
   PubMed Web of Science ®Google Scholar
• Block SL, Hedrick J, Harrison CJ et al. Community-wide vaccination with the heptavalent pneumococcal conjugate alters the microbiology of acute otitis media. Pediatr. Infect. Dis. J.23, 829–833 (2004).
   PubMed Web of Science ®Google Scholar
• Pelton SI, Loughlin AM, Marchant CD. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities. Changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr. Infect. Dis. J.23, 1015–1022 (2004).
   PubMed Web of Science ®Google Scholar
• Porat N, Barkai G, Jacobs MR, Trefler R, Dagan R. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J. Infect. Dis.189, 385–392 (2004).
   PubMedGoogle Scholar
• Porat N, Arguedas A, Spratt BG et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J. Infect. Dis.190, 2154–2161 (2004).
   PubMedGoogle Scholar
• Pelton SI, Huot H, Finkelstein JA et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J.26, 468–472 (2007).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA298, 1772–1778 (2007).
   PubMed Web of Science ®Google Scholar
• Klugman KP, McGee L. Resurgence of the multiresistant pneumococcus in the United States: a commentary. Pediatr. Infect. Dis. J.26, 473–474 (2007).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics and American Academy of Family Physicians. Clinical Practice Guideline. Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics113, 1451–1465 (2004).
   PubMed Web of Science ®Google Scholar
• Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J. Infect. Dis.175, 1440–1445 (1997).
   PubMed Web of Science ®Google Scholar
• Harabuchi Y, Faden H, Yamanaka N, Duffy L, Wolf J, Krystofik D. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. Tonawanda/Williamsville Pediatrics. J. Infect. Dis.170, 862–866 (1994).
   PubMed Web of Science ®Google Scholar
• Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr. Infect. Dis. J.13, 983–989 (1994).
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N. Engl. J. Med.340, 260–264 (1999).
   PubMed Web of Science ®Google Scholar
• Gungor A, Bluestone CD. Antibiotic theory in otitis media. Curr. Allergy Asthma Rep.1, 364–372 (2001).
   PubMedGoogle Scholar
• Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin. Infect. Dis.27, 764–770 (1998).
   PubMed Web of Science ®Google Scholar
• Dagan R. Clinical significance of resistant organisms in otitis media. Pediatr. Infect. Dis. J.19, 378–382 (2000).
   PubMedGoogle Scholar
• Sagraves R. Increasing antibiotic resistance: its effect on the therapy for otitis media. J. Pediatr. Health Care16, 79–85 (2002).
   PubMedGoogle Scholar
• Leibovitz E, Raiz S, Piglansly L et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr. Infect. Dis. J.17, 463–469 (1998).
   PubMedGoogle Scholar
• Leibovitz E, Dagan R. Otitis media therapy and drug resistance. Part 1: management principles. Infect. Med.18, 212–216 (2001).
   Google Scholar
• Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines. J. Infect. Dis.181, 1322–1329 (2000).
   PubMed Web of Science ®Google Scholar
• Leibovitz E. Complicated otitis media and its implications. Vaccine26S, G16–G19 (2008).
   Google Scholar
• Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr. Infect. Dis. J.12, 973–975 (1993).
   PubMedGoogle Scholar
• Leibovitz E, Greenberg D, Piglansky L et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr. Infect. Dis. J.22, 209–216 (2003).
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Yothers G, Dagan R et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr. Infect. Dis. J.21, 1008–1016 (2002).
   PubMed Web of Science ®Google Scholar
• Del Beccaro MA, Mendelman PM, Inglis AF et al. Bacteriology of acute otitis media: a new perspective. J. Pediatr.120, 81–84 (1992).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr. Infect. Dis. J.14, 178–183 (1995).
   PubMed Web of Science ®Google Scholar
• del Castillo F, Garcia-Perea A, Baquero-Artigao F. Bacteriology of acute otitis media in Spain: a prospective study based on tympanocentesis. Pediatr. Infect. Dis. J.15, 541–543 (1996).
   PubMed Web of Science ®Google Scholar
• Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lamas J, Doern GV. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A β-haemolytic streptococci in 2002–2003. Results of the multinational GRASP Surveillance Program. Int. J. Antimicrob. Agents25, 148–156 (2005).
   PubMed Web of Science ®Google Scholar
• Doern GV, Jones RN, Pfaller MA, Kugler K. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother.43, 385–389 (1999).
   PubMed Web of Science ®Google Scholar
• Kilpi T, Herva E, Kaijalainen T, SyrjanenR, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed fro the first two years of life. Pediatr. Infect. Dis. J.20, 654–662 (2001).
   PubMed Web of Science ®Google Scholar
• Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin. Infect. Dis.14, 1119–1123 (1992).
   PubMed Web of Science ®Google Scholar
• Mendelman PM, Chaffin DO, Stull TL et al. Characterization of nonβ-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother.25, 747–753 (1984).
   PubMedGoogle Scholar
• Hasegawa Y, Yamamoto K, Chiba N et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb. Drug Resist.9, 39–46 (2003).
   PubMed Web of Science ®Google Scholar
• Kaczmarek FS, Gootz TD, Dib-Hajj F, Shang W, Hallowell S, Cronan M. Genetic and molecular characterization of β-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob. Agents Chemother.48, 1630–1639 (2004).
   PubMed Web of Science ®Google Scholar
• Murphy TF, Kirkham C. Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol.2, 7 (2002).
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA296, 202–211 (2006).
   PubMed Web of Science ®Google Scholar
• Bakaletz LO. Bacterial biofilms in otitis media: evidence and relevance. Pediatr. Infect. Dis. J.26, S17–S19 (2007).
   PubMed Web of Science ®Google Scholar
• Bluestone C, Stephenson J, Martin L. Ten-year review of otitis media pathogens. Pediatr. Infect. Dis. J.11, S7–S11 (1992).
   PubMed Web of Science ®Google Scholar
• Guevara S, Soley C, Arguedas A, Porat N, Dagan R. Seasonal distribution of otitis media pathogens among Costa Rican children. Pediatr. Infect. Dis. J.27, 12–16 (2008).
   PubMedGoogle Scholar
• Broides A, Greenberg D, Givon-Lavi N, Leiberman A, Dagan R, Leibovitz E. Acute otitis media caused by Moraxella catarrhalis: epidemiologic and clinical characteristics. Presented at: 27th Annual Meeting of the European Society for Paediatric Infectious Diseases. Brussels, Belgium, 8–13 June 2009 (Abstract 586).
   Google Scholar
• Valentine E. Bacteriologic study of middle ear infections. J. Infect. Dis.35, 177–183 (1924).
   Google Scholar
• Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, Dagan R. Acute otitis media caused by Streptococcus pyogenes in children. Clin. Infect. Dis.41, 35–41 (2005).
   PubMed Web of Science ®Google Scholar
• Prymula R, Peeters P, Chrobok V et al. Pneumococcal capsular polysaccharide conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and nontypable Haemophilus influenzae: a randomized double-blind efficacy study. Lancet367, 740–848 (2006).
   PubMed Web of Science ®Google Scholar
• Poehling KA, Lafleur BJ, Szilagyi PG et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics114, 755–761 (2004).
   PubMed Web of Science ®Google Scholar
• Poehling KA, Szilagyi PG, Grijalva CG et al. Reduction of frequent otitis media and pressure-equilizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics119, 707–715 (2007).
   PubMed Web of Science ®Google Scholar
• Zhau F, Shefer A, Kong Y, Nuorti P. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004. Pediatrics121, 253–260 (2008).
   PubMedGoogle Scholar
• Richter SS, Heilmann KP, Dohrn CL, Rishi F, Beekmann SE, Doern GV. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004–2005. Clin. Infect. Dis.48, e23–e33 (2009).
   PubMed Web of Science ®Google Scholar
• Farrell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J.26, 123–128 (2007).
   PubMed Web of Science ®Google Scholar
• Dagan R, Givon-Lavi N, Zamir O et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine in toddlers attending day care centers. J. Infect. Dis.185, 927–936 (2002).
   PubMed Web of Science ®Google Scholar
• Dagan R, Givon-Lavi N, Zamir O, Frazer D. Effect of a nine-valent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day care centers. Pediatr. Infect. Dis. J.22, 532–539 (2003).
   PubMed Web of Science ®Google Scholar
• Ghaffar F, Barton T, Lozano J et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin. Infect. Dis.39, 930–938 (2004).
   PubMed Web of Science ®Google Scholar
• Brook I, Grober AE. Bacteriology of spontaneously draining acute otitis media in children before and after the introduction of pneumococcal vaccination. Pediatr. Infect. Dis J.28, 640–642 (2009).
   PubMedGoogle Scholar
• Pelton SI, Loughlin AM, Marchant CD. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities. Changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr. Infect. Dis. J.23, 1015–1022 (2004).
   PubMed Web of Science ®Google Scholar
• Porat N, Barkai G, Jacobs MR, Trefler R, Dagan R. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J. Infect. Dis.189, 385–392 (2004).
   PubMedGoogle Scholar
• Porat N, Arguedas A, Spratt BG et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J. Infect. Dis.190, 2154–2161 (2004).
   PubMedGoogle Scholar
• Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. Introduction and proliferation of multiresistant Streptococcus pneumoniae serotype 19A clones causing acute otitis media in an unvaccinated population. J. Infect. Dis.199, 776–785 (2009).
   PubMed Web of Science ®Google Scholar
• Rosenfeld RM, Vertrees JE, Carr J et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J. Pediatr.124, 355–367 (1994).
   PubMed Web of Science ®Google Scholar
• Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. Br. Med. J.314, 1526–1529 (1997).
   PubMed Web of Science ®Google Scholar
• Glasziou PP, Del Mar CB, Hayem M, Sanders SL. Antibiotics for acute otitis media in children. Cochrane Database Syst. Rev.1, CD000219 (2000).
   Google Scholar
• van Buchem FL, Peeters MF, van ‘t Hof MA. Acute otitis media: a new treatment strategy. Br. Med. J. (Clin. Res. Ed.)290, 1033–1037 (1985).
   PubMed Web of Science ®Google Scholar
• Little P, Gould C, Moore M, Warner G, Dunleavey J, Williamson I. Predictors of poor outcome and benefits from antibiotics in children with acute otitis media: pragmatic randomised trial. Br. Med. J.325, 1–6 (2002).
   PubMedGoogle Scholar
• Dagan R, McCracken GH Jr. Flaws in design and conduct of clinical trials in acute otitis media. Pediatr. Infec. Dis. J.21, 894–902 (2002).
   PubMedGoogle Scholar
• Wald E. Acute otitis media: more trouble with the evidence. Pediatr. Infect. Dis. J.22, 103–104 (2003).
   PubMedGoogle Scholar
• Pichichero ME, Casey JR. Comparison of study designs for acute otitis media trials. Int. J. Pediatr. Otolaryngol.72, 737–750 (2008).
   PubMedGoogle Scholar
• Pichichero ME, Casey JR. Diagnostic inaccuracy and subject exclusion render placebo and observational studies of acute otitis media inconclusive. Pediatr. Infect. Dis. J.27, 958–962 (2008).
   PubMed Web of Science ®Google Scholar
• Rovers MM, Glasziou P, Appelman CL et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet368, 1429–1435 (2006).
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Asher E, Piglansky L et al. Is bilateral acute otitis media clinically different than unilateral acute otitis media? Pediatr. Infect. Dis. J.26, 589–592 (2007).
   PubMed Web of Science ®Google Scholar
• Kaleida PH, Casselbrant ML, Rockette HE et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics87, 466–474 (1991).
   PubMed Web of Science ®Google Scholar
• Klein JO. The “in vivo sensitivity test” for acute otitis media revisited. Pediatr. Infect. Dis. J.17, 774–775 (1998).
   PubMedGoogle Scholar
• Dagan R, Leibovitz E. Bacterial eradication in the treatment of acute otitis media. Lancet Infect. Dis.2, 593–604 (2002).
   PubMed Web of Science ®Google Scholar
• Piglansky L, Leibovitz E, Raiz S et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr. Infect. Dis. J.22, 405–413 (2003).
   PubMed Web of Science ®Google Scholar
• Dagan R, Leibovitz E, Fliss DM et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob. Agents Chemother.44, 43–50 (2000).
   PubMed Web of Science ®Google Scholar
• Dagan R, Johnson CE, McLinn S et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr. Infect. Dis. J.19, 95–104 (2000).
   PubMed Web of Science ®Google Scholar
• Hoberman A, Dagan R, Leibovitz E et al. Large dosage amoxicillin/clavulanate compared with azithromycin for the treatment of bacterial acute otitis media in children. Pediatr. Infect. Dis. J.24, 525–532 (2005).
   PubMed Web of Science ®Google Scholar
• Scaglione F. Predicting the clinical efficacy of antibiotics: toward definitive criteria. Pediatr. Infect. Dis. J.16(Suppl.), S56–S59 (1997).
   PubMedGoogle Scholar
• Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother.39, 577–585 (1995).
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr. Infect. Dis. J.19, 1040–1045 (2000).
   PubMedGoogle Scholar
• Leiberman A, Leibovitz E, Piglansky L et al. The bacteriologic and clinical efficacy of trimethoprim/sulfamethoxazole in the treatment of acute otitis media in children. Pediatr. Infect. Dis. J.20, 260–264 (2001).
   PubMed Web of Science ®Google Scholar
• Dagan R, Schneider S, Givon-Lavi N et al. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children. Pediatr. Infect. Dis. J.27, 200–206 (2008).
   PubMedGoogle Scholar
• Asher E, Dagan R, Greenberg D et al. Persistence of pathogens despite clinical improvement in antibiotic-treated acute otitis media is associated with clinical and bacteriologic relapse. Pediatr. Infect. Dis. J.27, 296–301 (2008).
   PubMedGoogle Scholar
• Rodriguez WJ, Schwartz RH. Streptococcus pneumoniae causes otitis media with higher fever more redness of tympanic membrane than Haemophilus influenzae or Moraxella catarrhalis. Pediatr. Infect. Dis. J.18, 942–944 (1999).
   PubMedGoogle Scholar
• Palmu AA, Herva E, Savolainene H et al. Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin. Infect. Dis.83, 234–242 (2004).
   Google Scholar
• Olson LC, Jackson MA. Only the pneumococccus. Pediatr. Infect. Dis. J.81, 849–850 (1999).
   Google Scholar
• Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr. Infect. Dis. J.23, 1142–1155 (2004).
   PubMed Web of Science ®Google Scholar
• Barkai G, Leibovitz E, Givon-Lavi N, Dagan R. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr. Infect. Dis. J.28, 466–471 (2009).
   PubMed Web of Science ®Google Scholar
• Canafax DM, Yuan Z, Chonmaitree T et al. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr. Infect. Dis. J.17, 149–156 (1998).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Reed MD. Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media. Paediatr. Drugs11, 243–249 (2009).
   PubMedGoogle Scholar
• Dagan R, Hoberman A, Johnson C et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr. Infect. Dis. J.20, 829–837 (2001).
   PubMed Web of Science ®Google Scholar
• Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics115, 1048–1057 (2005).
   PubMed Web of Science ®Google Scholar
• Fenoll A, Gimenez MJ, Robledo O et al.In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae nonsusceptible to penicillin, amoxicillin or erythromycin. J. Chemother.20, 175–179 (2008).
   PubMed Web of Science ®Google Scholar
• Arguedas A, Emparanza P, Schwartz RH et al. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr. Infect. Dis. J.24, 153–161 (2005).
   PubMed Web of Science ®Google Scholar
• Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics91, 23–30 (1993).
   PubMed Web of Science ®Google Scholar
• Uhari M, Kontiokari T, Koskela M, Niemela M. Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial. Br. Med. J.313, 1180–1183 (1996).
   PubMed Web of Science ®Google Scholar
• Ukari M, Tapiainen T, Kontiokari T. Xylitol in preventing acute otitis media. Vaccine19, S144–S147 (2000).
   PubMedGoogle Scholar
• Hautalahti O, Renko M, TapiainenT, Kontiokari T, Pokka T, Uhari M. Failure of xylitol given three times a day for preventing acute otitis media. Pediatr. Infect. Dis. J.26, 423–427 (2007).
   PubMedGoogle Scholar
• Roos K, Grahn Hakansson E, Holm S. Effect of recolonization with ‘interfering’ a streptococci on recurrences of acute and secretory otitis media in children: randomized placebo controlled trials. Br. Med. J.322, 1–4 (2001).
   PubMedGoogle Scholar